U.S. sales of morning-after pill double

Jul 13, 2007

Sales of the morning-after pill Plan B in the United States have doubled since it was made available without a prescription.

Drug maker Barr Pharmaceuticals said sales will probably be close to $80 million for 2007, The Washington Post said Friday.

The Food and Drug Administration approved the sale of the controversial emergency contraceptive without a prescription for women 18 and older last August.

Women's health and family-planning advocates say it illustrates the value of easing access to birth control to help prevent unwanted pregnancies, the newspaper said.

Conservative groups, however, question the drug's safety and maintain the pill can cause the equivalent of an abortion.

Advocates would like to see the FDA remove the age restriction.

Copyright 2007 by United Press International

Explore further: Drug research and development more efficient than expected

add to favorites email to friend print save as pdf

Related Stories

Con artist who helped Google probe to be sentenced

Oct 23, 2011

(AP) -- A massive federal investigation that resulted in Google Inc. forfeiting $500 million this year to settle criminal claims over its advertising began with the 2008 arrest of a jet-setting career con artist, who took ...

30 years after first AIDS cases, hope for a cure

Jun 03, 2011

(AP) -- Sunday marks 30 years since the first AIDS cases were reported in the United States. And this anniversary brings fresh hope for something many had come to think was impossible: finding a cure.

US aims at its deadliest drug problem: painkillers

Apr 20, 2011

(AP) -- The White House drug czar wants doctors, states and law enforcement working harder to stop America's deadliest drug-abuse problem: highly addictive prescription painkillers. They are killing more ...

Watchdog group makes 2nd push to ban diet pill

Apr 18, 2011

(AP) -- For the second time in five years, public health advocates are calling on the Food and Drug Administration to ban a fat-blocking drug sold over-the counter and via prescription, pointing to new reports of kidney ...

Recommended for you

Drug research and development more efficient than expected

Feb 27, 2015

Drug R&D costs have increased substantially in recent decades, while the number of new drugs has remained fairly constant, leading to concerns about the sustainability of drug R&D and question about the factors that could ...

Use new meningitis vaccines only for outbreaks

Feb 26, 2015

(AP)—A U.S. panel on Thursday recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college students.

New antibiotic avycaz approved

Feb 26, 2015

(HealthDay)—The combination antibiotic Avycaz (ceftazidime-avibactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated infections of the intra-abdominal area or urinary tract, ...

Tagging drugs to fight counterfeit medicines

Feb 25, 2015

The U.S. and other countries are enacting rules to clamp down on the sales of fake pharmaceuticals, which pose a public health threat. But figuring out a system to track and authenticate legitimate drugs still faces significant ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.